BB BIOTECH AG - 01 Jun 2025 SCHEDULE 13G/A Report for Agios Pharmaceuticals, Inc. Common Stock (AGIO)

Filing Manager: BB BIOTECH AG
Reporting Manager: BB Biotech AG
Security: Agios Pharmaceuticals, Inc. Common Stock
Symbol: AGIO
Disclosed Ownership: 0 shares
Ownership: 0%
Form type: SCHEDULE 13G/A
Filing time: 13 Jun 2025, 14:50:40 UTC
Date of event: 01 Jun 2025
Previous filing: 14 Feb 2025
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
BB Biotech AG	0%	0	0	0	/s/ Christian Koch	Christian Koch/Signatory Authority
Biotech Target N.V.	0%	0	0	0	/s/ Jan Bootsma	Jan Bootsma/Signatory Authority